18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Depression
Brain imaging in bipolar depression to understand the antidepressant mechanism of lurasidone (Latuda).
Sponsor: Columbia University Irving Institute
Enrolling: Male and Female Patients
IRB Number: 7673
Contact: Martin Lan, MD, PHD: 646-774-7610 / martin.lan@nyspi.columbia.edu
Additional Study Information: We are trying to understand what causes bipolar disorder and how medications treat bipolar depression. Particularly, we are looking at the importance of dopamine signaling in the process. If you participate, you will have two different brain scans (MRI and PET scan). You will also have treatment for your depression with an FDA approved medication, lurasidone (Latuda). The study is funded by the Columbia University Irving Institute to improve the treatment of bipolar disorder. Please contact us if you are interested in participating.
This study is closed
Martin Lan, MD
Do You Qualify?
Do you have a diagnosis of bipolar disorder? Yes No
Are you currently having symptoms of depression? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Martin Lan, MD, PHD